Clinician-reviewed articles on treatments, costs, and what to expect — so you can make informed decisions at every step.
If you are switching from Ozempic (semaglutide) to Mounjaro (tirzepatide), the most important point is that there is no FDA-approved, milligram-for-milligram conversion between the two medicines. The numbers on the pens are not equivalent doses, and a higher number of milligrams does not mean that one product is simply a stronger version of the other.
Medications like Ozempic, Wegovy, and Mounjaro have significantly changed the landscape of treating type 2 diabetes and obesity. These drugs belong to a class known as GLP-1 receptor agonists, which help regulate blood glucose and promote substantial weight loss. However, a growing number of patients have raised concerns about hair loss after starting these medications.
Prediabetes often flies under the radar—until it doesn’t. With rising cases and growing concern around early intervention, more people are exploring new tools to slow the progression toward type 2 diabetes. One option gaining attention? Ozempic for prediabetes. Though not officially approved for this use, doctors are increasingly prescribing semaglutide for prediabetes off-label. This medication, originally designed for managing type 2 diabetes, may also support weight loss and improve insulin sensitivity. While Ozempic isn’t a standard prediabetes medication yet, it raises a big question: can Ozempic help prediabetes—and is it right for you?
Join 10,000+ others taking control of their well-being—from weight and energy to sexual health and mood—with board-certified providers.
From $145/mo
From $1.50/pill
From $92.33/mo
